Regeneron Pharmaceuticals Inc (REGN) Financials
Key financial figures for Regeneron Pharmaceuticals Inc (Q1 2026).
- Revenue
- $3.6B
- Net Income
- $727M
- EPS
- $6.99
- Total Assets
- $40.9B
- Operating Cash Flow
- $1.1B
Full income statement, balance sheet, and cash flow for Regeneron Pharmaceuticals Inc on SentiSense.